Viewing StudyNCT00135577



Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00135577
Status: COMPLETED
Last Update Posted: 2015-09-02
First Post: 2005-08-24

Brief Title: Study 767905008 Extension Study Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Sponsor: Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization: Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA

Conditions & Keywords Data

Conditions:
Name
Bowel Dysfunction
Cancer
Keywords:
Name View
opioid-induced bowel dysfunction View
opioids View
constipation View